The authors respond to letters on using prescribed psychostimulants to treat stimulant use disorder.
Heather N Palis, Scott MacDonald
Author Information
- Heather N Palis: Department of Psychiatry, University of British Columbia, Vancouver, BC.
- Scott MacDonald: Providence Health Care, Vancouver, BC.
No abstract text available.
- Cochrane Database Syst Rev. 2016 Sep 27;9:CD007380
[PMID: 27670244]
- CMAJ. 2023 Oct 10;195(39):E1356
[PMID: 37816525]
- Addiction. 2019 Jan;114(1):9-15
[PMID: 29900624]
- Psychopharmacology (Berl). 2020 Aug;237(8):2233-2255
[PMID: 32601988]
- Ann N Y Acad Sci. 2022 Feb;1508(1):3-22
[PMID: 34561865]
- Subst Abuse Treat Prev Policy. 2022 Aug 26;17(1):62
[PMID: 36028837]
- JAMA Psychiatry. 2023 Jan 1;80(1):31-39
[PMID: 36383348]
- J Epidemiol Community Health. 2020 Nov;74(11):964-968
[PMID: 32535550]
- CMAJ. 2023 Jul 17;195(27):E934-E935
[PMID: 37460124]
- PLoS One. 2021 May 26;16(5):e0252090
[PMID: 34038452]
- CMAJ. 2023 Oct 10;195(39):E1354
[PMID: 37816523]
- CMAJ. 2023 Oct 10;195(39):E1355
[PMID: 37816522]
- Front Psychiatry. 2022 Dec 02;13:1074691
[PMID: 36532164]
- J Addict Med. 2020 Dec;14(6):e287-e289
[PMID: 33009167]
Humans
Central Nervous System Stimulants
Attention Deficit Disorder with Hyperactivity
Central Nervous System Stimulants